Stay updated on 4 HSV-2 Vaccines in Adults With Recurrent Genital Herpes Clinical Trial
Sign up to get notified when there's something new on the 4 HSV-2 Vaccines in Adults With Recurrent Genital Herpes Clinical Trial page.

Latest updates to the 4 HSV-2 Vaccines in Adults With Recurrent Genital Herpes Clinical Trial page
- Check5 days agoChange DetectedThe study record for a Phase 1 trial of investigational HSV-2 vaccines is displayed, including its terminated status, study design, eligibility criteria, locations, and outcome measures.SummaryDifference93%

- Check12 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check19 days agoChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” It appears above the inaccessible study record.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer’s site revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe study page now displays a 403 Forbidden error page instead of the usual content. A Home button appears, indicating access to the record is blocked.SummaryDifference24%

Stay in the know with updates to 4 HSV-2 Vaccines in Adults With Recurrent Genital Herpes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 4 HSV-2 Vaccines in Adults With Recurrent Genital Herpes Clinical Trial page.